Fred Fleitz

Group Vice President, CMC at Arrowhead Pharmaceuticals

Speaker

Dr. Fleitz obtained his BS degree with a Chemistry major from Miami University in Oxford, Ohio. Upon completion of his studies there, he moved to Stanford University to pursue a doctoral degree under the direction of Professor Barry M Trost where his work included the development of palladium catalyzed reductive diyne cyclizations and the total synthesis of Siccanin. From Stanford, Dr. Fleitz moved to Merck and Co, in their Process Research department where he developed efficient, scaleable syntheses of small molecule drug candidates and was instrumental in the establishment of a biocatalysis group. After 14 years at Merck, Dr. Fleitz then moved to Cambridge Major Laboratories where he his work again focused on the process development of small molecules. In June of 2010 Dr. Fleitz moved to Arrowhead Research Corp., now Arrowhead Pharmaceuticals where he is currently the Group Vice President, Chemistry, Manufacturing, and Controls.